Australia's most trusted source of pharma news
Friday, 29 May 2020
Lost Your Access?
Cooking in their comfy clothes
Which pharma staff were baking or drinking in Covid
Tylenol arrives on Oz shores
Famous US pain brand here for a short time only
Biggest Aust Covid trial stalls
Researchers hit pause on 'Trump drug' study
Novel pill targets $130m market
Mayne looking at PBS for new contraceptive
Beware the black market: GPs
Opioid restrictions could fuel illegal drugs
TGA bans 'soldier on' campaigns
Cold, flu products must promote 'stay at home' message
Pharmas hit with $4.5m fine
UPDATED: GSK to pay after Voltaren Osteo breach
CSL a gamble for Covid vax
Biotech says sole manufacturer plan could backfire.
Doc visits crash as virtual soars
Latest MBS data show how Aussies shunned clinics
Who's at front of PBS queue?
New analysis reveals likely June listings
First Aussies get Covid vax
Melburnians get shots but vaccine can't be made here
Stoush erupts over flu shots
Docs, pharmacists are at it again
Oz manufacturing? Look to PBS
Lawyers argue 'blunt' local step-up unwarranted.
Novartis boosts patient groups
Commits funding, mental health services
New health alliance hits streets
Names 'overuse and overdiagnosis' as priority targets
Seqirus hogs limelight
Trends on flu jabs, pandemic preparedness.
Top of the Hill
Take the road less travelled
Which path will pharma leaders choose?
Roche's Rozlytrek ticked
Full registration paves way for listing.
Loneliness no aphrodisiac
People living alone doing it tougher than most
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design